Pacira BioSciences has patented a method for cryogenically treating target tissue to alleviate pain. The method involves using a cryogenic device with tissue-penetrating needles to cool the target tissue below the skin surface while applying warming energy to prevent collateral tissue damage, ultimately remodeling the tissue to alleviate pain. GlobalData’s report on Pacira BioSciences gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights Pacira BioSciences Inc - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Pacira BioSciences, Cancer treatment biomarkers was a key innovation area identified from patents. Pacira BioSciences's grant share as of May 2024 was 44%. Grant share is based on the ratio of number of grants to total number of patents.

Cryogenic method for treating target tissue to alleviate pain

Source: United States Patent and Trademark Office (USPTO). Credit: Pacira BioSciences Inc

A recently granted patent (Publication Number: US11963706B2) discloses a method for cryogenically treating target tissue to alleviate pain. The method involves using a cryogenic device with a tissue-penetrating needle probe, which has multiple spaced-apart needles to penetrate the tissue. These needles are cooled to treat the target tissue below the skin surface while applying warming energy to collateral tissue to prevent damage. The process aims to remodel the target tissue temporarily to alleviate pain, with specific dimensions and materials specified for the needles to ensure effectiveness and safety.

Furthermore, the patent details the use of a cooling fluid, such as nitrous oxide or carbon dioxide, delivered through the needle probe to provide the necessary cooling effect. The method also includes specific instructions for advancing the needles through the skin surface and applying warming energy to prevent collateral tissue damage. By combining cryogenic treatment with warming energy application, the method aims to remodel the target tissue effectively, providing temporary pain relief. Overall, the patent outlines a comprehensive approach to cryogenically treating target tissue for pain alleviation, emphasizing precision, safety, and efficacy in the process.

To know more about GlobalData’s detailed insights on Pacira BioSciences, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies